drugset / Trial / NCT04012775

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

NCT04012775

Phase 3 Completed 201 enrolled Geropharm
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is designed to approve non-inferior efficacy and safety of Rinsulin® NPH compared to Humulin® NPH.

Timeline

Start
2017-04-20
Primary completion
2018-09-24
Completion
2018-09-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic
Subject Rinsulin NPH Unknown